Plate 3*104 cell per well in 96-well plates in RPMI 1640 medium with 10%FBS for 24 h. Sub confluent cells were starved 4 h in RPMI 1640 medium with 2%FBS. Standard and Sample 2-human TNF- alpha were added and cell viability measured 24 h later by addition of CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay reagent (MTS). The ED50 for this effect is typically 0.02-0.08ng/ml.
Reinheit
> 97 % by SDS-PAGE.
Endotoxin-Niveau
level is less than 0.1 ng per myg (1EU/myg) of TNF-alpha
TNF alpha
Spezies: Human
Wirt: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
TNF alpha
Spezies: Hund
Wirt: Escherichia coli (E. coli)
Recombinant
Greater than 95 % by SDS-PAGE gel analyses
WB, ELISA
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Lagerung
-20 °C
Thuy, Thorsén: "Glycosylation profiling of therapeutic antibodies in serum samples using a microfluidic CD platform and MALDI-MS." in: Journal of the American Society for Mass Spectrometry, Vol. 24, Issue 7, pp. 1053-63, (2013) (PubMed).
Fritz, Radziwill: "CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling." in: Molecular cancer research : MCR, Vol. 8, Issue 3, pp. 395-406, (2010) (PubMed).
TNF-alpha plays a major role in growth regulation, differentiation, inflammation, viral replication, tumorigenesis, and autoimmune diseases. Besides inducing hemorrhagic necrosis of tumors, TNF has been found to be involved in tumorigenesis, tumor metastasis, viral replication, septic shock, fever, inflammation, and autoimmune diseases including Crohn's disease, and rheumatoid arthritis as well as graft-versus-host disease. TNF alpha-1a is a potent lymphoid factor that exerts cytotoxic effects on a wide range of tumor cells and certain other target cells. Synonym: TNF-alpha. Formulation: Lyophilized from a 0.2 mym filtered solution in PBS.